期刊文献+

人TRAIL胞外区原核可溶性表达及活性鉴定 被引量:1

Expression the tracellular domain of human TRAIL and identification of its activity
下载PDF
导出
摘要 目的获得具有生物活性的肿瘤坏死因子相关凋亡诱导配体(TRAIL)胞外段蛋白。方法根据大肠杆菌密码子偏爱性要求,设计合成编码TRAIL胞外段的DNA序列,构建成pET30a-TRAIL胞内融合表达质粒,重组质粒转化表达宿主E.coli BL21。在不同温度、不同浓度的IPTG条件下诱导表达TRAIL,SDS-PAGE分析表达产物,MTT法检测产物活性。结果构建的工程菌株表达29KD的可溶性TRAIL融合蛋白,能诱导Jurkat细胞凋亡。结论成功表达了人TRAIL胞外段蛋白,为进一步研究提供基础。 Objective To obtain the extracellular domain of tumor necrosis factor-related apoptosis-inducing ligand ( TRAIL) with activity . Methods We designed and synthesized DNA encoding the TRAIL extracellular DNA sequences according to the coding preference of the E .coli and constructed the prokaryotic expression vector :the pET30a TRAIL fusion expression plasmid . The recombinant plasmid was transformed into the expression host E .coli BL21 to induce expression under different temperature conditions , different concentrations of IPTG and alcohol . After inducing expression we used the SDS-PAGE method to analysis of expression product and used the MTT method to assay the activity of expression product .Results The constructed engineering bacteria expressed a 29KD soluble TRAIL fusion protein , and this protein can induce Jurkat cell apoptosis .Conclusion We successful express the extracellular domain of human TRAIL protein with activities .
出处 《河南大学学报(医学版)》 CAS 2014年第2期117-119,共3页 Journal of Henan University:Medical Science
基金 河南省医学科技攻关计划项目资助(WKJ2007-021)
关键词 原核表达 JURKAT细胞 凋亡 TRAIL TRAIL Prokaryotic expression Jurkat cells Apoptosis
  • 相关文献

参考文献7

二级参考文献14

  • 1Wiley SR, Schooley K, F,Smolak PJ, et al. Identification and characterization of a new menber of the TNF family that induces apoptods[J]. Immunity, 1995,3(6):673.
  • 2Pitti RM, Marsters SA, Ruppert S, et al. Induction of apoptosis by Apo-2 ligand,a new member of the tumor necrosis factor cytokine family [J] .J Biol Chem,1996,271(22) :12687.
  • 3Kayagaki N, Yamaguchi N, Nakayama M, et al . Type I intefferons(IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs [J].J Exp Med, 1999,189(9) :1451.
  • 4Gura T. How TRAIL kills cancer cells, but not normal cells [J].Science, 1997,277: 768.
  • 5Ashkenazi A, Pai RC, Fong S, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand[J]. J Clin Invest, 1999,104(2) : 155.
  • 6Wiley S R, Schooley K, Smolak P J et al. Identification and characterization of a new member of the TNF family that induces apoptosis[J]. Immunity, 1995; 3 (4) : 673-682.
  • 7Pitti R M, Marsters S A, Ruppert S et al. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family[J] .J Biol Chem, 1996;271(22) : 12687-12690.
  • 8Gura T. How TRAIL kills cancer cells, but not normal cells[J]. Science,1997;277(5327) :768-772.
  • 9Jo M, Kim T H, Seol D W et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand[J]. Nat Med,2000;6(5) :564-567.
  • 10Ozoren N, Kim K, Dicker D T et al. The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis inducing ligand[J]. Cancer Res,2000;60(22) :6259-6265.

共引文献9

同被引文献15

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部